Literature DB >> 2649187

Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

F Herrmann1, R Mertelsmann.   

Abstract

Recombinant DNA technology has been central in answering some of the most relevant questions in the research of regulation of the functional status of hematopoietic progenitor cells and their progeny. This leading article will focus on recent results that have emerged from studies utilizing recombinant molecules that control hematopoietic blood cell development and activation. The following features will be detailed: The molecular and biological characteristics and biochemistry of hematopoietic growth factors, synergizing factors and releasing factors, their role in the regulation of hematopoiesis and activation of normal and leukemic cells, their cellular sources, and regulation of production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649187     DOI: 10.1007/bf00320430

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  155 in total

1.  Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.

Authors:  M K Warren; P Ralph
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

2.  Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1.

Authors:  E R Stanley; A Bartocci; D Patinkin; M Rosendaal; T R Bradley
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

3.  Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome.

Authors:  A W Nienhuis; H F Bunn; P H Turner; T V Gopal; W G Nash; S J O'Brien; C J Sherr
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  A G Leary; Y C Yang; S C Clark; J C Gasson; D W Golde; M Ogawa
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

5.  Regulation of gene expression of M-, G-, GM-, and multi-CSF in normal and malignant hematopoietic cells.

Authors:  W Oster; A Lindemann; R Mertelsmann; F Herrmann
Journal:  Blood Cells       Date:  1988

6.  Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.

Authors:  M J Pettenati; M M Le Beau; R S Lemons; E A Shima; E S Kawasaki; R A Larson; C J Sherr; M O Diaz; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.

Authors:  P W Gray; B B Aggarwal; C V Benton; T S Bringman; W J Henzel; J A Jarrett; D W Leung; B Moffat; P Ng; L P Svedersky
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

8.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.

Authors:  G E Nedwin; S L Naylor; A Y Sakaguchi; D Smith; J Jarrett-Nedwin; D Pennica; D V Goeddel; P W Gray
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

9.  Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.

Authors:  A Zilberstein; R Ruggieri; J H Korn; M Revel
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor.

Authors:  S Nagata; M Tsuchiya; S Asano; O Yamamoto; Y Hirata; N Kubota; M Oheda; H Nomura; T Yamazaki
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

View more
  9 in total

Review 1.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms.

Authors:  A Bergamini; F Bolacchi; B Bongiovanni; M Cepparulo; L Ventura; M Capozzi; C Sarrecchia; G Rocchi
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

3.  Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.

Authors:  Hisaharu Shikata; Yoshihiro Yakushijin; Jun Yamanouchi; Taichi Azuma; Masaki Yasukawa
Journal:  Int J Clin Oncol       Date:  2013-02-05       Impact factor: 3.402

4.  Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemia.

Authors:  H Schrezenmeier; A Raghavachar; H Heimpel
Journal:  Clin Investig       Date:  1993-02

5.  Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice.

Authors:  F Abe; A Matsuda; M Schneider; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  An early effect of aflatoxin B1 administered in vivo on the growth of bone marrow CFU-GM and the production of some cytokines in rats.

Authors:  V Cukrová; N Kurita; M Akao
Journal:  Mycopathologia       Date:  1992-11       Impact factor: 2.574

7.  In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.

Authors:  N Van der Lely; T De Witte; J Wessels; R Raymakers; P Muus; F Preijers
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

8.  Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Authors:  P P Brons; C Haanen; J B Boezeman; P Muus; R S Holdrinet; A H Pennings; H M Wessels; T de Witte
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

Review 9.  Polypeptides controlling hematopoietic blood cell development and activation. II. Clinical results.

Authors:  F Herrmann; A Lindemann; R Mertelsmann
Journal:  Blut       Date:  1989-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.